This metabolite features a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 roughly 50% with the father or mother drug. Plasma concentrations of this metabolite are approximately 40% of Those people witnessed for sildenafil, so the metabolite accounts for approximately 20% of sildenafil's pharmacologic effects.It can be